{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:20:19Z","timestamp":1791210019866,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.euroneuro.2025.04.003","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T20:45:14Z","timestamp":1747946714000},"page":"46-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Pharmacological treatments for atypical depression: A systematic review and network meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9647-0853","authenticated-orcid":false,"given":"Michele","family":"Fornaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Caiazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9202-9307","authenticated-orcid":false,"given":"Luca","family":"Pistone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Di Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Crincoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Pezone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Tufano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5961-6032","authenticated-orcid":false,"given":"Vincenzo","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2032-1181","authenticated-orcid":false,"given":"Michele","family":"De Prisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2513-2718","authenticated-orcid":false,"given":"Alessandro","family":"Miola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"Iasevoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0548-0053","authenticated-orcid":false,"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Solmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"de Bartolomeis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2025.04.003_bib66","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0002","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0165-0327(02)00169-6","article-title":"Toward validation of atypical depression in the community: results of the Zurich cohort study","volume":"72","author":"Angst","year":"2002","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0001","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/10253890701378967","article-title":"HPA axis and sleep: identifying subtypes of major depression","volume":"11","author":"Antonijevic","year":"2008","journal-title":"Stress"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0003","series-title":"DSM-5-TR: Diagnostic and Statistical Manual of Mental Disorders","year":"2022"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v106.i02","article-title":"netmeta: an R package for network meta-analysis using frequentist methods","volume":"106","author":"Balduzzi","year":"2023","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0005","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/acps.13001","article-title":"How to choose an antidepressant medication","volume":"139","author":"Bayes","year":"2019","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0006","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jad.2012.02.011","article-title":"The predictive validity of atypical neurovegetative depressive symptoms identified by the first principal component in the DUAG trial of moclobemide versus clomipramine","volume":"140","author":"Bech","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0007","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1017\/S1092852919001378","article-title":"Commentary letter on \u201crevitalizing monoamine oxidase inhibitors: a call for action","volume":"25","author":"Cattaneo","year":"2020","journal-title":"CNS Spectr."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0008","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.euroneuro.2023.03.007","article-title":"Associations between individual depressive symptoms and immunometabolic characteristics in major depression","volume":"71","author":"Chae","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0009","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet North Am. Ed."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0010","first-page":"42","article-title":"Atypical depression in the 21st century: diagnostic and treatment issues","volume":"28","author":"Cristancho","year":"2011","journal-title":"Psychiatric Times"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib67","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jad.2025.02.034","article-title":"Atypical depression and emotion dysregulation: clinical and psychopathological features","volume":"376","author":"Fornaro","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0011","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.euroneuro.2014.04.004","article-title":"Duloxetine-bupropion combination for treatment-resistant atypical depression: a double-blind, randomized, placebo-controlled trial","volume":"24","author":"Fornaro","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0012","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.euroneuro.2024.04.016","article-title":"Network meta-analysis (NMA) of dextromethorphan-bupropion (AXS-05) efficacy and safety in major depressive disorder","volume":"86","author":"Gaca","year":"2024","journal-title":"Eur. Neuropsychopharmacol.: J. Eur. College Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0013","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/acps.13728","article-title":"Efficacy and tolerability of monoamine oxidase inhibitors for the treatment of depressive episodes in mood disorders: a systematic review and network meta-analysis","volume":"150","author":"Gim\u00e9nez-Palomo","year":"2024","journal-title":"Acta Psychiatr. Scand."},{"issue":"6","key":"10.1016\/j.euroneuro.2025.04.003_bib68","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/acps.13728","article-title":"Efficacy and tolerability of monoamine oxidase inhibitors for the treatment of depressive episodes in mood disorders: a systematic review and network meta-analysis","volume":"150","author":"Gim\u00e9nez-Palomo","year":"2024","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0014","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/sj.mp.4001032","article-title":"Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH\/NE states","volume":"7","author":"Gold","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/10401238909149966","article-title":"Bupropion and fluoxetine in depressive subtypes","volume":"1","author":"Goodnick","year":"1989","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0016","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0017","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.psychres.2005.07.012","article-title":"Treatment of depression with atypical features: a meta-analytic approach","volume":"141","author":"Henkel","year":"2006","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0018","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies","volume":"3","author":"Higgins","year":"2012","journal-title":"Res. Synth. Methods"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0019","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.3","author":"Higgins","year":"2022"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0020","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0021","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1001\/archpsyc.56.5.431","article-title":"Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial","volume":"56","author":"Jarrett","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0022","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/da.20001","article-title":"Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline","volume":"19","author":"Joyce","year":"2004","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13041-021-00879-3","article-title":"Impaired wakefulness and rapid eye movement sleep in dopamine-deficient mice","volume":"14","author":"Kashiwagi","year":"2021","journal-title":"Mol Brain"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0024","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejphar.2010.08.026","article-title":"Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats","volume":"647","author":"Kitaichi","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0025","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1600-0447.1991.tb03196.x","article-title":"Moclobemide in depression: a randomized, multicentre trial against isocarboxazide and clomipramine emphasizing atypical depression","volume":"84","author":"Larsen","year":"1991","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0026","series-title":"Different mechanisms between melancholic and atypical depression","author":"Lee","year":"2015"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0027","first-page":"22","article-title":"Psychopharmacologic validation of atypical depression","volume":"45","author":"Liebowitz","year":"1984","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0028","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/archpsyc.1988.01800260037004","article-title":"Antidepressant specificity in atypical depression","volume":"45","author":"Liebowitz","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0029","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/biom.12817","article-title":"Quantifying publication bias in meta-analysis","volume":"74","author":"Lin","year":"2018","journal-title":"Biometrics"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0030","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.2147\/NDT.S147317","article-title":"Atypical depression: current perspectives","author":"\u0141ojko","year":"2017","journal-title":"Neuropsychiatr. Dis. Treatm."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0031","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0165-0327(94)90015-9","article-title":"Moclobemide and fluoxetine in atypical depression: a double-blind trial","volume":"32","author":"Lonnqvist","year":"1994","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0032","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archpsyc.1989.01810010047007","article-title":"A controlled study of the antidepressant efficacy and side effects of (\u2014)-deprenyl: a selective monoamine oxidase inhibitor","volume":"46","author":"Mann","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0033","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/ebmental-2019-300104","article-title":"Network meta-analysis in a nutshell","volume":"22","author":"Mavridis","year":"2019","journal-title":"Evid. Based Ment. Health"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0034","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1176\/appi.ajp.157.3.344","article-title":"A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of atypical depression","volume":"157","author":"McGrath","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0035","article-title":"Pathophysiological models of hypersomnolence associated with depression","author":"Moderie","year":"2024","journal-title":"Biol. Psychiat. Global Open Sci."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0036","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0037","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1017\/S1461145704004717","article-title":"Hypericum extract in patients with MDD and reversed vegetative signs: re-analysis from data of a double-blind, randomized trial of hypericum extract, fluoxetine, and placebo","volume":"8","author":"Murck","year":"2005","journal-title":"Int. J. Neuropsychopharmacolog."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: an approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"Nikolakopoulou","year":"2020","journal-title":"PLoS Med."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0039","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jad.2022.10.003","article-title":"Melancholic features and typical neurovegetative symptoms of major depressive disorder show specific polygenic patterns","volume":"320","author":"Oliva","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0040","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S2215-0366(24)00006-3","article-title":"Pharmacological treatments for psychotic depression: a systematic review and network meta-analysis","volume":"11","author":"Oliva","year":"2024","journal-title":"Lancet Psychiat."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0041","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/0006-3223(95)00628-1","article-title":"Fluoxetine versus phenelzine in atypical depression","volume":"40","author":"Pande","year":"1996","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0042","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/archpsyc.1991.01810280035005","article-title":"Response to Phenelzine and Imipramine in Placebo nonresponders with Atypical depression - a new application of the crossover design","volume":"48","author":"Quitkin","year":"1991","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0043","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/archpsyc.1990.01810220051006","article-title":"Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication","volume":"47","author":"Quitkin","year":"1990","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0044","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/archpsyc.1989.01810090029005","article-title":"Phenelzine and imipramine in mood reactive depressives - further delineation of the syndrome of Atypical depression","volume":"46","author":"Quitkin","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib65","doi-asserted-by":"crossref","first-page":"d549","DOI":"10.1136\/bmj.d549","article-title":"Interpretation of random effects meta-analyses","volume":"342","author":"Riley","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0045","series-title":"the Treatment of Depressive-Anxiety States: A Controlled Clinical Trial","article-title":"The monoamine oxidase inhibitor, phenelzine","author":"Robinson","year":"1973"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0046","series-title":"WebPlotDigitizer","author":"Rohatgi","year":"2017"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0047","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.euroneuro.2023.03.012","article-title":"Efficacy and safety of selegiline across different psychiatric disorders: a systematic review and meta-analysis of oral and transdermal formulations","volume":"72","author":"Rossano","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0048","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11739-016-1583-7","article-title":"Network meta-analysis: an introduction for clinicians","volume":"12","author":"Rouse","year":"2017","journal-title":"Int. Emerg. Med."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0049","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","article-title":"Ranking treatments in frequentist network meta-analysis works without resampling methods","volume":"15","author":"R\u00fccker","year":"2015","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0050","article-title":"Management of depression in adults: a review","author":"Simon","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0051","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/026988119901300412","article-title":"A 12-week study comparing moclobemide and sertraline in the treatment of outpatients with atypical depression","volume":"13","author":"S\u00f8gaard","year":"1999","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0052","first-page":"366","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised crossover trials (beta)","author":"Sterne","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0053","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/PSY.0b013e31820ad12b","article-title":"Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research","volume":"73","author":"Stetler","year":"2011","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0054","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1176\/ajp.149.5.615","article-title":"Can mildly depressed outpatients with Atypical depression benefit from antidepressants","volume":"149","author":"Stewart","year":"1992","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0055","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1001\/archpsyc.1989.01810120022005","article-title":"Relevance of DMS-III depressive subtype and chronicity of antidepressant efficacy in atypical depression. Differential response to phenelzine, imipramine, and placebo","volume":"46","author":"Stewart","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0056","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00004850-199100630-00007","article-title":"A double-blind parallel study comparing fluoxetine with imipramine in the treatment of Atypical depression","volume":"6","author":"Stratta","year":"1991","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0057","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1007\/BF02850218","article-title":"Comparison of the effectiveness of reboxetine versus fluoxetine in patients with atypical depression: a single-blind randomized clinical trial","volume":"23","author":"Taner","year":"2006","journal-title":"Adv. Ther."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0058","series-title":"R: A language and environment for statistical computing","author":"Team","year":"2023"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0059","first-page":"5","article-title":"Treatment of imipramine-resistant recurrent depression .3. Efficacy of monoamine-oxidase inhibitors","volume":"53","author":"Thase","year":"1992","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0060","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.jcp.0000227700.263.75.39","article-title":"Modafinil for atypical depression: effects of open-label and double-blind discontinuation treatment","volume":"26","author":"Vaishnavi","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0061","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1017\/S1092852922000906","article-title":"The prescriber\u2019s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression","volume":"28","author":"Van den Eynde","year":"2023","journal-title":"CNS Spectr."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0062","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/ije\/dys222","article-title":"Evaluation of inconsistency in networks of interventions","volume":"42","author":"Veroniki","year":"2013","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0063","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.euroneuro.2024.08.512","article-title":"Psychiatric first-aid kit: a review of EMA's critical medicines list","volume":"89","author":"Vieta","year":"2024","journal-title":"Eur. Neuropsychopharmacol.: J. Eur. College Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2025.04.003_bib0064","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S2215-0366(23)00199-2","article-title":"Comparative efficacy and tolerability of pharmacological interventions for acute bipolar depression in adults: a systematic review and network meta-analysis","volume":"10","author":"Yildiz","year":"2023","journal-title":"Lancet Psychiat."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X25000823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X25000823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T01:28:53Z","timestamp":1749691733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X25000823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":68,"alternative-id":["S0924977X25000823"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2025.04.003","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological treatments for atypical depression: A systematic review and network meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2025.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. and ECNP. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}